FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019931785> ?p ?o ?g. }

• W2019931785 endingPage "148" @default.
• W2019931785 startingPage "139" @default.
• W2019931785 abstract "The prevalence of anxiety and depression in patients with advanced cancer has been reported to be on average 25% and to significantly affect patients' quality of life. Despite high prevalence rates, these disorders remain underdiagnosed and undertreated. The purpose of our study was to examine the self-report rates of anxiety and depression with the Edmonton Symptom Assessment System (ESAS) and to assess the predictive factors for these reports in cancer patients with metastatic disease.Consecutive patients who attended the Rapid Response Radiotherapy Program (RRRP) completed the ESAS as well as baseline demographic information. Ordinal logistic regression analysis was used to determine factors that significantly predicted anxiety and/or depression. Pearson χ(2) was used to test goodness-of-fit for categorical variables and established whether or not an observed frequency distribution differed from a predicted frequency distribution. A univariate analysis was conducted first and those variables with a P value<0.100 were included in a multivariate analysis. A score test was used to test the proportional odds assumption.In total, 1439 patients seen in the RRRP between January 1999 and October 2009 completed ESAS questionnaires. Fifty-five per cent of patients reported at least mild symptoms of depression and 65% reported at least mild anxiety. In the univariate analysis, patients who were female, who had a lower performance status score, or primary lung cancer were more likely to report depressed and anxious feelings. Primary prostate cancer patients were significantly less likely to report depression and anxiety. Patients referred for spinal cord compression were significantly less depressed. The multivariate models showed that younger patients were significantly more anxious than older patients and females reported more anxiety than males. Patients who reported higher feelings of nausea, tiredness, drowsiness, dyspnoea, and worse appetite and overall well-being on the ESAS tool were more likely to report feelings of depression. Patients who reported higher nausea, drowsiness, dyspnoea and worse overall well-being more often reported higher feelings of anxiety.The self-report rates of anxiety and depression were consistent with published prevalence rates. However, the explained variance based on factors included in the model remains low. Additional predictive factors should be examined in future studies in this population. The ESAS tool seems to be an efficient screening tool for anxiety and depression; however, future studies should examine its correlative properties with other known screening tools in the advanced cancer population. A prospective study should be conducted to assess the severity cut-off point in which the ESAS scores most frequently lead to a further diagnosis of an anxiety or depressive disorder in the advance cancer population." @default.
• W2019931785 created "2016-06-24" @default.
• W2019931785 creator A5006315627 @default.
• W2019931785 creator A5019513454 @default.
• W2019931785 creator A5029099061 @default.
• W2019931785 creator A5032559235 @default.
• W2019931785 creator A5035792596 @default.
• W2019931785 creator A5047114036 @default.
• W2019931785 creator A5053082490 @default.
• W2019931785 creator A5063388495 @default.
• W2019931785 creator A5070451444 @default.
• W2019931785 creator A5087956624 @default.
• W2019931785 date "2012-03-01" @default.
• W2019931785 modified "2023-09-26" @default.
• W2019931785 title "Frequency of Reporting and Predictive Factors for Anxiety and Depression in Patients with Advanced Cancer" @default.
• W2019931785 cites W1793637796 @default.
• W2019931785 cites W1956286140 @default.
• W2019931785 cites W1971198533 @default.
• W2019931785 cites W1981592659 @default.
• W2019931785 cites W1981707025 @default.
• W2019931785 cites W1985955058 @default.
• W2019931785 cites W1995724573 @default.
• W2019931785 cites W1999867088 @default.
• W2019931785 cites W2005305063 @default.
• W2019931785 cites W2012160863 @default.
• W2019931785 cites W2028353688 @default.
• W2019931785 cites W2028702088 @default.
• W2019931785 cites W2046687511 @default.
• W2019931785 cites W2063388266 @default.
• W2019931785 cites W2065621119 @default.
• W2019931785 cites W2066835394 @default.
• W2019931785 cites W2111457041 @default.
• W2019931785 cites W2115111325 @default.
• W2019931785 cites W2123608275 @default.
• W2019931785 cites W2126362960 @default.
• W2019931785 cites W2150004057 @default.
• W2019931785 cites W2161943291 @default.
• W2019931785 cites W2167503015 @default.
• W2019931785 cites W2171773335 @default.
• W2019931785 cites W4233408923 @default.
• W2019931785 doi "https://doi.org/10.1016/j.clon.2011.05.003" @default.
• W2019931785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21652191" @default.
• W2019931785 hasPublicationYear "2012" @default.
• W2019931785 type Work @default.
• W2019931785 sameAs 2019931785 @default.
• W2019931785 citedByCount "67" @default.
• W2019931785 countsByYear W20199317852012 @default.
• W2019931785 countsByYear W20199317852013 @default.
• W2019931785 countsByYear W20199317852014 @default.
• W2019931785 countsByYear W20199317852015 @default.
• W2019931785 countsByYear W20199317852016 @default.
• W2019931785 countsByYear W20199317852017 @default.
• W2019931785 countsByYear W20199317852018 @default.
• W2019931785 countsByYear W20199317852019 @default.
• W2019931785 countsByYear W20199317852020 @default.
• W2019931785 countsByYear W20199317852021 @default.
• W2019931785 countsByYear W20199317852022 @default.
• W2019931785 countsByYear W20199317852023 @default.
• W2019931785 crossrefType "journal-article" @default.
• W2019931785 hasAuthorship W2019931785A5006315627 @default.
• W2019931785 hasAuthorship W2019931785A5019513454 @default.
• W2019931785 hasAuthorship W2019931785A5029099061 @default.
• W2019931785 hasAuthorship W2019931785A5032559235 @default.
• W2019931785 hasAuthorship W2019931785A5035792596 @default.
• W2019931785 hasAuthorship W2019931785A5047114036 @default.
• W2019931785 hasAuthorship W2019931785A5053082490 @default.
• W2019931785 hasAuthorship W2019931785A5063388495 @default.
• W2019931785 hasAuthorship W2019931785A5070451444 @default.
• W2019931785 hasAuthorship W2019931785A5087956624 @default.
• W2019931785 hasConcept C118552586 @default.
• W2019931785 hasConcept C121608353 @default.
• W2019931785 hasConcept C126322002 @default.
• W2019931785 hasConcept C139719470 @default.
• W2019931785 hasConcept C144301174 @default.
• W2019931785 hasConcept C151956035 @default.
• W2019931785 hasConcept C162324750 @default.
• W2019931785 hasConcept C1862650 @default.
• W2019931785 hasConcept C2776256026 @default.
• W2019931785 hasConcept C2776867660 @default.
• W2019931785 hasConcept C38180746 @default.
• W2019931785 hasConcept C558461103 @default.
• W2019931785 hasConcept C71924100 @default.
• W2019931785 hasConceptScore W2019931785C118552586 @default.
• W2019931785 hasConceptScore W2019931785C121608353 @default.
• W2019931785 hasConceptScore W2019931785C126322002 @default.
• W2019931785 hasConceptScore W2019931785C139719470 @default.
• W2019931785 hasConceptScore W2019931785C144301174 @default.
• W2019931785 hasConceptScore W2019931785C151956035 @default.
• W2019931785 hasConceptScore W2019931785C162324750 @default.
• W2019931785 hasConceptScore W2019931785C1862650 @default.
• W2019931785 hasConceptScore W2019931785C2776256026 @default.
• W2019931785 hasConceptScore W2019931785C2776867660 @default.
• W2019931785 hasConceptScore W2019931785C38180746 @default.
• W2019931785 hasConceptScore W2019931785C558461103 @default.
• W2019931785 hasConceptScore W2019931785C71924100 @default.
• W2019931785 hasIssue "2" @default.
• W2019931785 hasLocation W20199317851 @default.
• W2019931785 hasLocation W20199317852 @default.

• next